ZMOMP

Zentrum für Molekulare Onkologie und Molekularpathologie 

Prof. Dr. med
Hans Bojar

Prof. Dr. med
Christopher Poremba

Prof. Dr. med
Veit Krenn


trans

Preface

Our goal is to offer our patients , referring physicians as well as respondents a high-tech laboratory platform to support efforts to treat  the cancer patients in a personal way according to the individual risk and predicted drug sensitivity. In the awareness e of the pronounced molecular individuality of cancerous diseases we have pooled knowledge, experience and state-of-the-art technologies enabling a reliable, trustful molecular characterization of individual malignant tumors thus paving the way for an optimized cancer therapy.